The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study

Objectives: The usefulness of serial procalcitonin (PCT) measurements for predicting the prognosis and treatment efficacy for hospitalised community-acquired pneumonia (CAP) patients was investigated. Methods: This prospective, multicentre, cohort study enrolled consecutive CAP patients who were hos...

Full description

Bibliographic Details
Main Authors: Akihiro Ito, Isao Ito, Daiki Inoue, Satoshi Marumo, Tetsuya Ueda, Hiroaki Nakagawa, Masato Taki, Atsushi Nakagawa, Shuji Tatsumi, Takashi Nishimura, Tetsuhiro Shiota, Tadashi Ishida
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220300205
id doaj-109c1aa0f9ca4f39ae310faf6ed944e2
record_format Article
spelling doaj-109c1aa0f9ca4f39ae310faf6ed944e22020-11-25T01:01:15ZengElsevierInternational Journal of Infectious Diseases1201-97122020-03-0192228233The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective studyAkihiro Ito0Isao Ito1Daiki Inoue2Satoshi Marumo3Tetsuya Ueda4Hiroaki Nakagawa5Masato Taki6Atsushi Nakagawa7Shuji Tatsumi8Takashi Nishimura9Tetsuhiro Shiota10Tadashi Ishida11Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Corresponding author at: Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan.Department of Respiratory Medicine, Kyoto University Hospital, 54 Shogoinkawara-cho, Sakyo-ku, Kyoto, Kyoto 606-8507, JapanDepartment of Respiratory Medicine, Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, 2-4-20 Ougimachi, Kita-ku, Osaka, Osaka 530-8480, JapanDepartment of Respiratory Medicine, Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, 2-4-20 Ougimachi, Kita-ku, Osaka, Osaka 530-8480, JapanDepartment of Respiratory Medicine, Osaka Saiseikai Nakatsu Hospital, 2-10-39 Shibata, Kita-ku, Osaka, Osaka 530-0012, JapanDepartment of Respiratory Medicine, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, JapanDepartment of Respiratory Medicine, Osaka Red Cross Hospital, 5-30 Fudegasaki, Tennoji-ku, Osaka, Osaka 543-8555, JapanDepartment of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JapanDepartment of Airway Medicine, Mitsubishi Kyoto Hospital, 1 Katsuragosho-cho, Saikyo-ku, Kyoto, Kyoto 615-8087, JapanDepartment of Respiratory Medicine, Kyoto Katsura Hospital, 17 Yamadahirao-cho, Saikyo-ku, Kyoto, Kyoto 615-8256, JapanDepartment of Internal Medicine, Yoka Hospital, 1878-1 Yoka, Yoka-cho, Yabu, Hyogo 667-8555, Japan; Department of Respiratory Medicine, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524, JapanDepartment of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, JapanObjectives: The usefulness of serial procalcitonin (PCT) measurements for predicting the prognosis and treatment efficacy for hospitalised community-acquired pneumonia (CAP) patients was investigated. Methods: This prospective, multicentre, cohort study enrolled consecutive CAP patients who were hospitalised at 10 hospitals in western Japan from September 2013 to September 2016. PCT and C-reactive protein (CRP) were measured on admission (PCT D1 and CRP D1), within 48–72 h after admission (PCT D3 and CRP D3), and within 144–192 h after admission. CURB-65 and the Pneumonia Severity Index (PSI) were assessed on admission. The primary outcome was 30-day mortality; secondary outcomes were early and late treatment failure rates. Results: A total of 710 patients were included. The 30-day mortality rate was 3.1%. On multivariate analysis, only PCT D3/D1 ratio >1 [odds ratio (95% confidence interval): 4.33 (1.46–12.82),P = 0.008] and PSI [odds ratio (95% confidence interval): 2.32 (1.07–5.03), P = 0.03] were significant prognostic factors. Regarding treatment efficacy, PCT D3/D1 >1 was a significant predictor of early treatment failure on multivariate analysis. PCT D3/D1 with the PSI significantly improved the prognostic accuracy over that of the PSI alone. Conclusions: PCT should be measured consecutively, not only on admission, to predict the prognosis and treatment efficacy in CAP. Keywords: Biomarker, C-reactive protein, Pneumonia, Procalcitonin, Prognosishttp://www.sciencedirect.com/science/article/pii/S1201971220300205
collection DOAJ
language English
format Article
sources DOAJ
author Akihiro Ito
Isao Ito
Daiki Inoue
Satoshi Marumo
Tetsuya Ueda
Hiroaki Nakagawa
Masato Taki
Atsushi Nakagawa
Shuji Tatsumi
Takashi Nishimura
Tetsuhiro Shiota
Tadashi Ishida
spellingShingle Akihiro Ito
Isao Ito
Daiki Inoue
Satoshi Marumo
Tetsuya Ueda
Hiroaki Nakagawa
Masato Taki
Atsushi Nakagawa
Shuji Tatsumi
Takashi Nishimura
Tetsuhiro Shiota
Tadashi Ishida
The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study
International Journal of Infectious Diseases
author_facet Akihiro Ito
Isao Ito
Daiki Inoue
Satoshi Marumo
Tetsuya Ueda
Hiroaki Nakagawa
Masato Taki
Atsushi Nakagawa
Shuji Tatsumi
Takashi Nishimura
Tetsuhiro Shiota
Tadashi Ishida
author_sort Akihiro Ito
title The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study
title_short The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study
title_full The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study
title_fullStr The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study
title_full_unstemmed The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study
title_sort utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: a multicentre, prospective study
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
publishDate 2020-03-01
description Objectives: The usefulness of serial procalcitonin (PCT) measurements for predicting the prognosis and treatment efficacy for hospitalised community-acquired pneumonia (CAP) patients was investigated. Methods: This prospective, multicentre, cohort study enrolled consecutive CAP patients who were hospitalised at 10 hospitals in western Japan from September 2013 to September 2016. PCT and C-reactive protein (CRP) were measured on admission (PCT D1 and CRP D1), within 48–72 h after admission (PCT D3 and CRP D3), and within 144–192 h after admission. CURB-65 and the Pneumonia Severity Index (PSI) were assessed on admission. The primary outcome was 30-day mortality; secondary outcomes were early and late treatment failure rates. Results: A total of 710 patients were included. The 30-day mortality rate was 3.1%. On multivariate analysis, only PCT D3/D1 ratio >1 [odds ratio (95% confidence interval): 4.33 (1.46–12.82),P = 0.008] and PSI [odds ratio (95% confidence interval): 2.32 (1.07–5.03), P = 0.03] were significant prognostic factors. Regarding treatment efficacy, PCT D3/D1 >1 was a significant predictor of early treatment failure on multivariate analysis. PCT D3/D1 with the PSI significantly improved the prognostic accuracy over that of the PSI alone. Conclusions: PCT should be measured consecutively, not only on admission, to predict the prognosis and treatment efficacy in CAP. Keywords: Biomarker, C-reactive protein, Pneumonia, Procalcitonin, Prognosis
url http://www.sciencedirect.com/science/article/pii/S1201971220300205
work_keys_str_mv AT akihiroito theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT isaoito theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT daikiinoue theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT satoshimarumo theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT tetsuyaueda theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT hiroakinakagawa theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT masatotaki theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT atsushinakagawa theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT shujitatsumi theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT takashinishimura theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT tetsuhiroshiota theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT tadashiishida theutilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT akihiroito utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT isaoito utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT daikiinoue utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT satoshimarumo utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT tetsuyaueda utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT hiroakinakagawa utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT masatotaki utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT atsushinakagawa utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT shujitatsumi utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT takashinishimura utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT tetsuhiroshiota utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
AT tadashiishida utilityofserialprocalcitoninmeasurementsinadditiontopneumoniaseverityscoresinhospitalisedcommunityacquiredpneumoniaamulticentreprospectivestudy
_version_ 1725209870606532608